Biased usage of synovial immunoglobulin heavy chain variable region 4 by the anti-glucose-6-phosphate isomerase antibody in patients with rheumatoid arthritis

International Journal of Molecular Medicine

Volumn 20, Issue 2, 2007, Pages 247-253

  Hayashi, Taichi ^a   Matsumoto, Isao ^a,b   Yasukochi, Takanori ^a,b   Mamura, Mizuko ^a   Goto, Daisuke ^a   Ito, Satoshi ^a   Tsutsumi, Akito ^a   Sumida, Takayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Autoantibodies; B cells; Glucose 6 phosphate isomerase; Rheumatoid arthritis; Synovium

Indexed keywords

AUTOANTIBODY; GLUCOSE 6 PHOSPHATE ISOMERASE; IMMUNOGLOBULIN HEAVY CHAIN;

AGED; AMINO ACID SEQUENCE; ARTICLE; FEMALE; GENE AMPLIFICATION; GENETICS; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

AGED; AMINO ACID SEQUENCE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; GENE AMPLIFICATION; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SYNOVIAL FLUID;

EID: 35448948402     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.2.247     Document Type: Article

References (43)

1. Firestein GS: Evolving concepts of rheumatoid arthritis. Nature 423: 356-361, 2003.
2. Silverman GJ and Carson DA: Roles of B cells in rheumatoid arthritis. Arthritis Res Ther 5 (suppl 4): S1-S6, 2003.
3. Leandro MJ, Edwards JC and Cambridge G: Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis 61: 883-888, 2002.
4. Higashida J, Wun T, Schmidt S, et al: Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment. J Rheumatol 32: 2109-2115, 2005.
5. Matsumoto I, Staub A, Benoist C, et al: Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286: 1732-1735, 1999.
6. Benoist C and Mathis D: A revival of the B cell paradigm for rheumatoid arthritis pathogenesis? Arthritis Res 2: 90-94, 2000.
7. Matsumoto I, Maccioni M, Lee DM, et al: How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 3: 360-365, 2002.
8. Kouskoff V, Korganow AS, Duchatelle V, et al: Organ-specific disease provoked by systemic autoimmunity. Cell 87: 811-822, 1996.
9. Schaller M, Burton DR and Ditzel H: Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol 2: 746-753, 2001.
10. van Gaalen FA, Toes RE, Ditzel HJ, et al: Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis. Arthritis Rheum 50: 395-399, 2004.
11. Jouen F, Vittecoq O, Leguillou F, et al: Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis. Clin Exp Immunol 137: 606-611, 2004.
12. Matsumoto I, Lee DM, Goldbach-Mansky R, et al: Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum 48: 944-954, 2003.
13. Hayashi T, Matsumoto I, Muraki Y, et al: Clinical characteristics of anti-glucose-6-phosphate isomerase antibody-positive Japanese patients with rheumatoid arthritis. Mod Rheumatol 15: 258-263, 2005.
14. Schaller M, Stohl W, Tan SM, et al: Raised levels of antiglucose-6- phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann Rheum Dis 64: 743-749, 2005.
15. Cha HS, Kim TJ, Kim JY, et al: Autoantibodies to glucose-6-phosphate isomerase are elevated in the synovial fluid of rheumatoid arthritis patients. Scand J Rheumatol 33: 179-184, 2004.
16. Kim JY, Lee MH, Jung KI, et al: Detection of antibodies against glucose 6-phosphate isomerase in synovial fluid of rheumatoid arthritis using surface plasmon resonance (BIAcore). Exp Mol Med 35: 310-316, 2003.
17. Matsuda F, Ishii K, Bourvagnet P, et al: The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 188: 2151-2162, 1998.
18. Pascual V and Capra JD: VH4-21, a human VH gene segment overrepresented in the autoimmune repertoire. Arthritis Rheum 35: 11-18, 1992.
19. Brezinschek HP, Brezinschek RI and Lipsky PE: Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 155: 190-202, 1995.
20. Pugh-Bernard AE, Silverman GJ, Cappione AJ, et al: Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 108: 1061-1070, 2001.
21. Kim HJ, Krenn V, Steinhauser G, et al: Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J Immunol 162: 3053-3062, 1999.
22. Voswinkel J, Trümper L, Carbon G, et al: Evidence for a selected humoral immune response encoded by VH4 family genes in the synovial membrane of a patient with rheumatoid arthritis. Clin Exp Immunol 106: 5-12, 1996.
23. Brown CM, Longhurst C, Haynes G, et al: Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue. Clin Exp Immunol 89: 230-238, 1992.
24. Gause A, Gundlach K, Carbon G, et al: Analysis of VH gene rearrangements from synovial B cells of patients with rheumatoid arthritis reveals infiltration of the synovial membrane by memory B cells. Rheumatol Int 17: 145-150, 1997.
25. Voswinkel J, Weisgerber K, Pfreundschuh M, et al: The B lymphocyte in rheumatoid arthritis: recirculation of B lymphocytes between different joints and blood. Autoimmunity 31: 25-34, 1999.
26. Schröder AE, Greiner A, Seyfert C, et al: Differentiation of B cells in the non-lymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA 93: 221-225, 1996.
27. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324, 1988.
28. Souto-Carneiro MM, Longo NS, Russ DE, et al: Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J Immunol 172: 6790-6802, 2004.
29. Suzuki T, Muraki Y, Yasukochi T, et al: Immunoglobulin G from anti-glucose-6-phosphate isomerase antibodies positive patient with rheumatoid arthritis induces synovitis in cynomolgus monkeys. Autoimmun Rev 4: 475-478, 2005.
30. van Vollenhoven RF, Bieber MM, Powell MJ, et al: VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics. J Rheumatol 26: 1727-1733, 1999.
31. Bhat NM, Lee LM, van Vollenhoven RF, et al: VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype. J Rheumatol 29: 2114-2121, 2002.
32. Huang SC, Jiang R, Hufnagle WO, et al: VH usage and somatic hypermutation in peripheral blood B cells of patients with rheumatoid arthritis (RA). Clin Exp Immunol 112: 516-527, 1998.
33. Chang B and Casali P: The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 15: 367-373, 1994.
34. Waisman A, Shoenfeld Y, Blank M, et al: The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment. Int Immunol 7: 689-696, 1995.
35. Denomme GA, Mahmoudi M, Cairns E, et al: Immunoglobulin V region sequences of two human antiplatelet monoclonal autoantibodies derived from B cells of normal origin. J Autoimmun 7: 521-535, 1994. (Pubitemid 24268390)
36. Rahman A: Autoantibodies, lupus and the science of sabotage. Rheumatology 43: 1326-1336, 2004.
37. Giles I, Lambrianides N, Latchman D, et al: The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. Arthritis Res Ther 7: 47-56, 2005.
38. Xiang J, Chen Z, Delbaere LT, et al: Differences in antigen-binding affinity caused by a single amino acid substitution in the variable region of the heavy chain. Immunol Cell Biol 71: 239-247, 1993.
39. Rosner K, Winter DB, Tarone RE, et al: Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes. Immunology 103: 179-187, 2001.
40. Xue W, Luo S, Adler WH, et al: Immunoglobulin heavy chain junctional diversity in young and aged humans. Hum Immunol 57: 80-92, 1997.
41. Wang X and Stollar D: Immunoglobulin VH gene expression in human aging. Clin Immunol 93: 132-142, 1999.
42. McHeyzer-Williams MG, McLean MJ, Lalor PA, et al: Antigen-driven B cell differentiation in vivo. J Exp Med 178: 295-307, 1993.
43. Brezinschek HP, Foster SJ, Dorner T, et al: Pairing of variable heavy and variable k chains in individual naïve and memory B cells. J Immunol 160: 4762-4767, 1998.